Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	IGc2	NPHS1 FLT4 MXRA5 SIRPB2 IGDCC4 HMCN2 HMCN1 FGFR3 MDGA1 SDK1 LILRB5 ALPK2 CDON MYBPC2	2.24e-09	235	138	14	SM00408
Domain	Ig_sub2	NPHS1 FLT4 MXRA5 SIRPB2 IGDCC4 HMCN2 HMCN1 FGFR3 MDGA1 SDK1 LILRB5 ALPK2 CDON MYBPC2	2.24e-09	235	138	14	IPR003598
Domain	Ig_I-set	NPHS1 FLT4 MXRA5 IGDCC4 HMCN2 HMCN1 FGFR3 MDGA1 SDK1 ALPK2 CDON MYBPC2	1.73e-08	190	138	12	IPR013098
Domain	I-set	NPHS1 FLT4 MXRA5 IGDCC4 HMCN2 HMCN1 FGFR3 MDGA1 SDK1 ALPK2 CDON MYBPC2	1.73e-08	190	138	12	PF07679
Domain	Ig-like_dom	NPHS1 FLT3 FLT4 MXRA5 SIRPB2 LEPR IGDCC4 HMCN2 HMCN1 CSF3R FGFR3 MDGA1 SDK1 LILRB5 ALPK2 CDON AMIGO2 MYBPC2	3.35e-08	503	138	18	IPR007110
Domain	Ig-like_fold	NPHS1 FLT3 FLT4 IL31RA MXRA5 TSPOAP1 SIRPB2 LEPR IGDCC4 HMCN2 HMCN1 CSF3R FGFR3 MDGA1 TNR SDK1 LILRB5 ALPK2 CDON AMIGO2 MYBPC2	5.32e-08	706	138	21	IPR013783
Domain	IG	NPHS1 FLT3 FLT4 MXRA5 SIRPB2 IGDCC4 HMCN2 HMCN1 FGFR3 MDGA1 SDK1 LILRB5 ALPK2 CDON AMIGO2 MYBPC2	9.09e-08	421	138	16	SM00409
Domain	Ig_sub	NPHS1 FLT3 FLT4 MXRA5 SIRPB2 IGDCC4 HMCN2 HMCN1 FGFR3 MDGA1 SDK1 LILRB5 ALPK2 CDON AMIGO2 MYBPC2	9.09e-08	421	138	16	IPR003599
Domain	-	NPHS1 FLT3 FLT4 IL31RA MXRA5 TSPOAP1 SIRPB2 LEPR IGDCC4 HMCN1 CSF3R FGFR3 MDGA1 TNR SDK1 LILRB5 ALPK2 CDON AMIGO2 MYBPC2	9.11e-08	663	138	20	2.60.40.10
Domain	FN3	NPHS1 IL31RA TSPOAP1 LEPR IGDCC4 CSF3R MDGA1 TNR SDK1 CDON MYBPC2	1.29e-07	185	138	11	SM00060
Domain	IG_LIKE	NPHS1 FLT3 FLT4 MXRA5 SIRPB2 LEPR IGDCC4 HMCN2 HMCN1 FGFR3 MDGA1 SDK1 LILRB5 ALPK2 CDON AMIGO2 MYBPC2	1.33e-07	491	138	17	PS50835
Domain	FN3	NPHS1 IL31RA TSPOAP1 LEPR IGDCC4 CSF3R MDGA1 TNR SDK1 CDON MYBPC2	2.70e-07	199	138	11	PS50853
Domain	FN3_dom	NPHS1 IL31RA TSPOAP1 LEPR IGDCC4 CSF3R MDGA1 TNR SDK1 CDON MYBPC2	4.41e-07	209	138	11	IPR003961
Domain	fn3	NPHS1 IL31RA TSPOAP1 IGDCC4 CSF3R TNR SDK1 CDON MYBPC2	3.28e-06	162	138	9	PF00041
Domain	ig	NPHS1 FLT3 FLT4 HMCN1 FGFR3 MDGA1 LILRB5 CDON AMIGO2	1.20e-05	190	138	9	PF00047
Domain	Immunoglobulin	NPHS1 FLT3 FLT4 HMCN1 FGFR3 MDGA1 LILRB5 CDON AMIGO2	1.20e-05	190	138	9	IPR013151
Domain	MTMR12-like_C	MTMR12 MTMR11	1.62e-04	3	138	2	IPR022587
Domain	3-PAP	MTMR12 MTMR11	1.62e-04	3	138	2	PF12578
Domain	G2F	HMCN2 HMCN1	3.22e-04	4	138	2	PF07474
Domain	Lep_receptor_Ig	LEPR CSF3R	3.22e-04	4	138	2	PF06328
Domain	NIDOGEN_G2	HMCN2 HMCN1	3.22e-04	4	138	2	PS50993
Domain	GFP	HMCN2 HMCN1	3.22e-04	4	138	2	IPR009017
Domain	IgC2-like_lig-bd	LEPR CSF3R	3.22e-04	4	138	2	IPR010457
Domain	G2_nidogen/fibulin_G2F	HMCN2 HMCN1	3.22e-04	4	138	2	IPR006605
Domain	HnRNP_R/Q_splicing_fac	SYNCRIP HNRNPR	5.34e-04	5	138	2	IPR006535
Domain	Hematopoietin_rcpt_Gp130_CS	LEPR CSF3R	1.11e-03	7	138	2	IPR003529
Domain	Tyr_kinase_rcpt_3_CS	FLT3 FLT4	1.47e-03	8	138	2	IPR001824
Domain	HEMATOPO_REC_L_F2	LEPR CSF3R	1.47e-03	8	138	2	PS01353
Domain	RECEPTOR_TYR_KIN_III	FLT3 FLT4	1.47e-03	8	138	2	PS00240
Pubmed	Allele-specific binding of ZFP57 in the epigenetic regulation of imprinted and non-imprinted monoallelic expression.	ZNF444 TRIM73 TRIM74	2.56e-06	7	147	3	26025256
Pubmed	Identification of Serhl, a new member of the serine hydrolase family induced by passive stretch of skeletal muscle in vivo.	SERHL2 SERHL	1.77e-05	2	147	2	11352564
Pubmed	Protein N-arginine methyltransferase 5 promotes the tumor progression and radioresistance of nasopharyngeal carcinoma.	PRMT5 FGFR3	1.77e-05	2	147	2	26708443
Pubmed	Identification of Tyr438 as the major in vitro c-Src phosphorylation site in human gelsolin: a mass spectrometric approach.	GSN CSK	1.77e-05	2	147	2	10210201
Pubmed	Novel role for the nuclear phosphoprotein SET in transcriptional activation of P450c17 and initiation of neurosteroidogenesis.	SET CYP17A1	1.77e-05	2	147	2	10847589
Pubmed	Activation of the G-CSF and Flt-3 receptors protects hematopoietic stem cells from lethal irradiation.	FLT3 CSF3R	1.77e-05	2	147	2	14585378
Pubmed	Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues.	HMCN2 HMCN1	1.77e-05	2	147	2	32035013
Pubmed	Gelsolin and ceruloplasmin as potential predictive biomarkers for cervical cancer by 2D-DIGE proteomics analysis.	CP GSN	1.77e-05	2	147	2	23925487
Pubmed	Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene.	FLT3 FLT4	1.77e-05	2	147	2	1319394
Pubmed	The arginine methyltransferase PRMT5 regulates CIITA-dependent MHC II transcription.	CIITA PRMT5	1.77e-05	2	147	2	26972221
Pubmed	Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians.	CYP17A1 HECTD4 FIGN	3.98e-05	16	147	3	21572416
Pubmed	Five friends of methylated chromatin target of protein-arginine-methyltransferase[prmt]-1 (chtop), a complex linking arginine methylation to desumoylation.	SET TAF1A PRMT5	4.82e-05	17	147	3	22872859
Pubmed	Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere.	HMCN2 HMCN1	5.31e-05	3	147	2	12388743
Pubmed	PRMT5/FGFR3/AKT Signaling Axis Facilitates Lung Cancer Cell Metastasis.	PRMT5 FGFR3	5.31e-05	3	147	2	36927233
Pubmed	Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS.	SYNCRIP HNRNPR	5.31e-05	3	147	2	30755280
Pubmed	The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophosphamide or interleukin-8 but not flt-3 ligand.	FLT3 CSF3R	5.31e-05	3	147	2	9326216
Pubmed	Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.	PRMT5 FGFR3	5.31e-05	3	147	2	29679612
Pubmed	A secreted protein promotes cleavage furrow maturation during cytokinesis.	HMCN2 HMCN1	5.31e-05	3	147	2	21215633
Pubmed	Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.	PRMT5 FGFR3	5.31e-05	3	147	2	26078354
Pubmed	Nephrin, a transmembrane protein, is involved in pancreatic beta-cell survival signaling.	NPHS1 LEPR	5.31e-05	3	147	2	25448064
Pubmed	Aberrant Expression of FBXO2 Disrupts Glucose Homeostasis Through Ubiquitin-Mediated Degradation of Insulin Receptor in Obese Mice.	LEPR FBXO2	5.31e-05	3	147	2	27932386
Pubmed	Gene structure variation in segmental duplication block C of human chromosome 7q 11.23 during primate evolution.	TRIM73 TRIM74	5.31e-05	3	147	2	26196062
Pubmed	MLL histone methylases regulate expression of HDLR-SR-B1 in presence of estrogen and control plasma cholesterol in vivo.	KMT2D SCARB1	5.31e-05	3	147	2	23192982
Pubmed	Hemicentins assemble on diverse epithelia in the mouse.	HMCN2 HMCN1	5.31e-05	3	147	2	17015624
Pubmed	Parental and offspring contribution of genetic markers of adult blood pressure in early life: The FAMILY study.	CYP17A1 CSK	5.31e-05	3	147	2	29045471
Pubmed	TRIM50 protein regulates vesicular trafficking for acid secretion in gastric parietal cells.	TRIM73 TRIM74	5.31e-05	3	147	2	22872646
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	NLRP11 LEPR KMT2D DDX50 SUPT16H LRBA HNRNPR	6.54e-05	234	147	7	36243803
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	FLT3 IGDCC4 HMCN1 MDGA1 CDON AMIGO2	6.85e-05	162	147	6	25826454
Pubmed	Recapitulation of four hypertension susceptibility genes (CSK, CYP17A1, MTHFR, and FGF5) in East Asians.	CYP17A1 CSK	1.06e-04	4	147	2	22959498
Pubmed	Hemicentin 1 influences podocyte dynamic changes in glomerular diseases.	LEPR HMCN1	1.06e-04	4	147	2	29488390
Pubmed	Neph1, a component of the kidney slit diaphragm, is tyrosine-phosphorylated by the Src family tyrosine kinase and modulates intracellular signaling by binding to Grb2.	NPHS1 CSK	1.06e-04	4	147	2	18258597
Pubmed	Association of the 19S proteasomal ATPases with the ATPase-binding domain of CIITA is essential for CIITA stability and MHC class II expression.	PSMC2 CIITA	1.06e-04	4	147	2	20351748
Pubmed	Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons?	SYNCRIP HNRNPR	1.06e-04	4	147	2	11773003
Pubmed	Soluble thrombopoietin receptor (Mpl) and granulocyte colony-stimulating factor receptor directly stimulate proliferation of primitive hematopoietic progenitors of mice in synergy with steel factor or the ligand for Flt3/Flk2.	FLT3 CSF3R	1.06e-04	4	147	2	8943846
Pubmed	SMN interacts with a novel family of hnRNP and spliceosomal proteins.	SYNCRIP HNRNPR	1.06e-04	4	147	2	11574476
Pubmed	Vertebrate extracellular matrix protein hemicentin-1 interacts physically and genetically with basement membrane protein nidogen-2.	HMCN2 HMCN1	1.06e-04	4	147	2	36007682
Pubmed	GPR120 suppresses adipose tissue lipolysis and synergizes with GPR40 in antidiabetic efficacy.	FFAR1 LEPR	1.06e-04	4	147	2	28583918
Pubmed	Mechanisms to Elevate Endogenous GLP-1 Beyond Injectable GLP-1 Analogs and Metabolic Surgery.	FFAR1 LEPR	1.06e-04	4	147	2	29203510
Pubmed	Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17.	SET CYP17A1	1.06e-04	4	147	2	12444089
Pubmed	Hemicentin-1 is an essential extracellular matrix component of the dermal-epidermal and myotendinous junctions.	HMCN2 HMCN1	1.06e-04	4	147	2	34504132
Pubmed	Induced chromosome deletions cause hypersociability and other features of Williams-Beuren syndrome in mice.	TRIM73 TRIM74	1.76e-04	5	147	2	20049703
Pubmed	Williams-Beuren syndrome TRIM50 encodes an E3 ubiquitin ligase.	TRIM73 TRIM74	1.76e-04	5	147	2	18398435
Pubmed	PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease.	MTMR12 MTMR11	1.76e-04	5	147	2	12495846
Pubmed	Association of common variants in/near six genes (ATP2B1, CSK, MTHFR, CYP17A1, STK39 and FGF5) with blood pressure/hypertension risk in Chinese children.	CYP17A1 CSK	2.63e-04	6	147	2	23759979
Pubmed	TRIM50 regulates Beclin 1 proautophagic activity.	TRIM73 TRIM74	2.63e-04	6	147	2	29604308
Pubmed	Epsin deficiency promotes lymphangiogenesis through regulation of VEGFR3 degradation in diabetes.	FLT4 LEPR	2.63e-04	6	147	2	30102256
Pubmed	TRIM50 promotes NLRP3 inflammasome activation by directly inducing NLRP3 oligomerization.	TRIM73 TRIM74	2.63e-04	6	147	2	36178239
Pubmed	Human endogenous retrovirus HERV-K(HML-2) proviruses with Rec protein coding capacity and transcriptional activity.	ERVK-9 ERVK-19	2.63e-04	6	147	2	15063128
Pubmed	Cyclic AMP-stimulated interaction between steroidogenic factor 1 and diacylglycerol kinase theta facilitates induction of CYP17.	CYP17A1 DGKQ	2.63e-04	6	147	2	17664281
Pubmed	Transcriptional landscape of pulmonary lymphatic endothelial cells during fetal gestation.	FLT4 IFIT1B	3.67e-04	7	147	2	31083674
Pubmed	A novel TBP-associated factor of SL1 functions in RNA polymerase I transcription.	SET TAF1A	3.67e-04	7	147	2	17318177
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	SF3B4 MARS1 DDX52 PSMC2 USP5 SUPT16H NCAPD2 LRBA SYNCRIP HNRNPR	4.04e-04	638	147	10	33239621
Pubmed	The protein tyrosine kinase family of the human genome.	FLT3 FLT4 CSK FGFR3	4.34e-04	83	147	4	11114734
Pubmed	Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism.	LEPR SCARB1	4.89e-04	8	147	2	33462514
Pubmed	Identification of methylated proteins by protein arginine N-methyltransferase 1, PRMT1, with a new expression cloning strategy.	SYNCRIP HNRNPR	4.89e-04	8	147	2	12183049
Pubmed	NFATc1 regulates lymphatic endothelial development.	FLT4 FGFR3	4.89e-04	8	147	2	19233265
Pubmed	FGF-dependent metabolic control of vascular development.	FLT4 FGFR3	4.89e-04	8	147	2	28467822
Pubmed	Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome.	NPHS1 FLT4	4.89e-04	8	147	2	15465483
Pubmed	Noncanonical function of glutamyl-prolyl-tRNA synthetase: gene-specific silencing of translation.	CP SYNCRIP	4.89e-04	8	147	2	15479637
Pubmed	Identification of a heterogeneous nuclear ribonucleoprotein-recognition region in the HIV Rev protein.	SYNCRIP HNRNPR	4.89e-04	8	147	2	19808671
Pubmed	Cullin-3/KCTD10 complex is essential for K27-polyubiquitination of EIF3D in human hepatocellular carcinoma HepG2 cells.	IRGQ SCARB1 SYNCRIP HNRNPR	5.90e-04	90	147	4	31280863
Pubmed	Influence of pharmacogenetic variability on the pharmacokinetics and toxicity of the aurora kinase inhibitor danusertib.	FLT3 FLT4	6.26e-04	9	147	2	20182906
Pubmed	The role of WDR5 in silencing human fetal globin gene expression.	KMT2D PRMT5	6.26e-04	9	147	2	22689669
Pubmed	An investigation into the human serum "interactome".	NPHS1 CP GSN IGDCC4 ADRA1B	6.47e-04	162	147	5	15174051
Pubmed	Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer.	FLT3 FLT4 FGFR3	6.52e-04	40	147	3	30898150
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	MARS1 LARS2 GSN DDX50 TLE1 PRMT5 SYNCRIP HNRNPR	6.98e-04	451	147	8	36168627
Pubmed	Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure.	CYP17A1 FIGN CSK	7.53e-04	42	147	3	21909110
Pubmed	Analysis of a novel human gene, LOC92912, over-expressed in hypopharyngeal tumours.	GSN PRMT5	7.81e-04	10	147	2	16300736
Pubmed	The fanconi anemia core complex acts as a transcriptional co-regulator in hairy enhancer of split 1 signaling.	FANCG TLE1	7.81e-04	10	147	2	19321451
Pubmed	Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein.	SET TAF1A	7.81e-04	10	147	2	11163245
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	SET INTS1 DNAAF8 PHF1 KMT2D PRMT5 SUPT16H NCAPD2	8.98e-04	469	147	8	27634302
Pubmed	RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway.	SYNCRIP HNRNPR	9.52e-04	11	147	2	37142680
Pubmed	SYNCRIP, a cytoplasmic counterpart of heterogeneous nuclear ribonucleoprotein R, interacts with ubiquitous synaptotagmin isoforms.	SYNCRIP HNRNPR	9.52e-04	11	147	2	10734137
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	SF3B4 MARS1 DDX52 SEZ6L2 GSN DDX50 PRMT5 SUPT16H SYNCRIP HNRNPR	9.56e-04	714	147	10	28302793
Pubmed	Functional proteomics mapping of a human signaling pathway.	FLT4 ZFYVE16 KDM3B PSMC2 PPP1R15A USP5 KMT2D MTMR11 SDK1	9.63e-04	591	147	9	15231748
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	SET TBRG4 SF3B4 MARS1 PSMC2 PFAS GSN USP5 PRMT5 SUPT16H NCAPD2 PPIL2 TFB2M SYNCRIP HNRNPR	1.00e-03	1415	147	15	28515276
Pubmed	Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation.	SET MARS1 PSMC2 USP5 SUPT16H	1.04e-03	180	147	5	30110629
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	SET TBRG4 SF3B4 MARS1 PSMC2 PFAS IRGQ GSN CDAN1 TLE1 FAM83G LRBA SYNCRIP HNRNPR	1.13e-03	1284	147	14	17353931
Pubmed	The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation.	SYNCRIP HNRNPR	1.14e-03	12	147	2	16236758
Pubmed	A signaling role of histone-binding proteins and INHAT subunits pp32 and Set/TAF-Ibeta in integrating chromatin hypoacetylation and transcriptional repression.	SET TAF1A	1.14e-03	12	147	2	15136563
Pubmed	Systematic analysis of myotubularins: heteromeric interactions, subcellular localisation and endosome related functions.	MTMR12 MTMR11	1.14e-03	12	147	2	16787938
Pubmed	Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy.	TENT4A PISD	1.14e-03	12	147	2	23776197
Pubmed	Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.	ERVK-9 ERVK-19	1.14e-03	12	147	2	14557543
Pubmed	Recapitulation of two genomewide association studies on blood pressure and essential hypertension in the Korean population.	CYP17A1 CSK	1.14e-03	12	147	2	20414254
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SET DDX52 ABCB5 STARD10 SERP1 EPX LRRC43 DDX50 SUPT16H NCAPD2 GPR171 AMIGO2 SYNCRIP HNRNPR MYBPC2	1.21e-03	1442	147	15	35575683
Pubmed	Genomic analysis of mouse retinal development.	PITPNM2 FLT3 SET STARD10 KDM3B SEZ6L2 PRMT5 SUPT16H NCAPD2 PISD FGFR3 ALDH3B1	1.21e-03	1006	147	12	15226823
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	SET MARS1 KDM3B PSMC2 PFAS DPP3 CDAN1 USP5 PRMT5 CIAPIN1 SUPT16H NCAPD2 LRBA SYNCRIP HNRNPR	1.32e-03	1455	147	15	22863883
Pubmed	UIF, a New mRNA export adaptor that works together with REF/ALY, requires FACT for recruitment to mRNA.	SET SUPT16H	1.34e-03	13	147	2	19836239
Pubmed	Testis Determination Requires a Specific FGFR2 Isoform to Repress FOXL2.	CYP17A1 FGFR3	1.34e-03	13	147	2	28938467
Pubmed	Blood pressure and hypertension are associated with 7 loci in the Japanese population.	CYP17A1 CSK	1.34e-03	13	147	2	20479155
Pubmed	A Combinatorial CRISPR-Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment.	FLT4 FGFR3	1.34e-03	13	147	2	34666996
Pubmed	The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing.	SF3B4 PRMT5	1.34e-03	13	147	2	17218272
Pubmed	A candidate gene study of obstructive sleep apnea in European Americans and African Americans.	LEPR ADRA1B FGFR3	1.40e-03	52	147	3	20538960
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	ZFYVE16 ATL1 SLC30A6 RUFY2 INF2 SCARB1 MARVELD2 LRBA	1.42e-03	504	147	8	34432599
Pubmed	Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia.	SIRPB2 SMG8	1.56e-03	14	147	2	23620142
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MTMR12 SF3B4 ZFYVE16 PSMC2 PFAS KMT2D MTMR11 DDX50 CSK CSPG5 SUPT16H MARVELD2	1.72e-03	1049	147	12	27880917
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	FAT4 KDM3B OCRL SLC30A6 DDX50 SLFN13 MARVELD2 LRBA SDK1 CDON	1.79e-03	777	147	10	35844135
Pubmed	Functional redundancy of frizzled 3 and frizzled 6 in planar cell polarity control of mouse hair follicles.	SERHL2 SERHL	1.80e-03	15	147	2	30237242
Pubmed	The BRCT-domain containing protein PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex.	KMT2D PRMT5	1.80e-03	15	147	2	17925232
Pubmed	Transgenerational epigenetic effects imposed by neonicotinoid thiacloprid exposure.	CYP17A1 ZIC5 SCARB1	1.93e-03	58	147	3	37973188
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	FLT4 MXRA5 IGDCC4 HMCN2 HMCN1 FGFR3 MDGA1 SDK1 ALPK2 CDON MYBPC2	1.02e-09	161	97	11	593
GeneFamily	Immunoglobulin like domain containing	NPHS1 FLT3 FLT4 MXRA5 LEPR IGDCC4 HMCN2 MDGA1 SDK1 CDON AMIGO2	6.90e-09	193	97	11	594
GeneFamily	Fibronectin type III domain containing	NPHS1 IL31RA TSPOAP1 IGDCC4 CSF3R TNR SDK1 CDON MYBPC2	1.95e-07	160	97	9	555
GeneFamily	Fibulins	HMCN2 HMCN1	7.81e-04	8	97	2	556
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	FLT3 FLT4 FGFR3	1.28e-03	40	97	3	321
GeneFamily	Myotubularins\|Phosphoinositide phosphatases	MTMR12 MTMR11	2.86e-03	15	97	2	903
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Lpl-Cadm2_(Layer_2/3,_Cadm2+)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	PKD1L2 EPX LRRC43 CIITA	1.85e-05	48	146	4	bbfc33299ea8e6895dd4d21a7dd38bec33563127
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SEZ6L2 ATL1 CDAN1 DDX50 PRMT5 EXOC3L1	1.95e-05	168	146	6	53a982869dbf14f6a948589be9f2f3df3b9a7e97
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	FLT3 B3GLCT ZSCAN25 FBXO2 FANCG EML5	1.95e-05	168	146	6	8459d0a1bf6d4b5c83001097331f8b78fceb9305
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	INTS1 CP ZRANB3 IGDCC4 MTMR11 FGFR3	2.09e-05	170	146	6	b1a16600754e0c12f7d39c9221f1b03135833f16
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FAT4 TSPOAP1 OCRL ZRANB3 HMCN1 NCAPD2	2.23e-05	172	146	6	c6bc78fd63c9479a84ec0552b55c89750cad0fa5
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FAT4 TSPOAP1 OCRL ZRANB3 HMCN1 NCAPD2	2.23e-05	172	146	6	bfb87a281a9cf6ad45b310bf8104fc0ab382b549
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	APCDD1 GNG13 IGDCC4 FAM83G SDK1 CDON	2.70e-05	178	146	6	c77a1d1a9aef0ab51b4408b9e84f201219788ca2
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT4 FIGN SEZ6L2 IGDCC4 ADRA1B SDK1	2.79e-05	179	146	6	c7afbd10072d36a35cd20ae73670d76b9cefd22d
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC46A2 IRX5 STARD10 CP BTG3 GALNT5	2.79e-05	179	146	6	7db6b97a1c4c7a163d5da4351ba36ac1785d9d7b
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL15A1 FIGN SEZ6L2 ADRA1B HMCN2 SDK1	2.97e-05	181	146	6	35bcdcd2651149692e5b150e887c0f450c81d2d4
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC46A2 IRX5 STARD10 CP BTG3 GALNT5	3.06e-05	182	146	6	1e2149b222a3e9f64841aed45288a6f29394e7b0
ToppCell	wk_20-22-Mesenchymal-Chondrocyte-Resting_chondrocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MXRA5 B3GLCT COL15A1 FIGN C17orf113 PUS10	3.06e-05	182	146	6	03a5a02acd48f0eb210485348bfe0cd21f486215
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC46A2 IRX5 STARD10 CP BTG3 GALNT5	3.25e-05	184	146	6	157a3d00165bb4a8c52c3e63ae57d9cf57500be7
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC46A2 CP FIGN GALNT5 LRBA CDON	3.35e-05	185	146	6	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL15A1 FIGN SEZ6L2 ADRA1B NPTXR SDK1	3.35e-05	185	146	6	caf4f57f2db9ff72a652c8573e16e7ab180ffc05
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT4 ABCB5 SEZ6L2 IGDCC4 ADRA1B NPTXR	4.01e-05	191	146	6	764c3a8829ae1253a0790744138266e81fc075ec
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-cDC2\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLT3 SIRPB2 GSN CSF3R CIITA CSK	4.01e-05	191	146	6	a898153490fb9e8c4331c5dce63dbfb5185bccf2
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT4 ABCB5 SEZ6L2 IGDCC4 ADRA1B SDK1	4.13e-05	192	146	6	3abee376c37c3646da33ac381aa63d50a01607a6
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FAT4 MXRA5 LEPR HMCN1 NPTXR FGFR3	4.25e-05	193	146	6	cf2461af78f65616ce40d552ee9452295e3895ed
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FAT4 MXRA5 LEPR HMCN1 NPTXR FGFR3	4.25e-05	193	146	6	6ef9007c9d18fb775d08fb20cdf954a28d54d7eb
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FAT4 MXRA5 LEPR HMCN1 NPTXR FGFR3	4.25e-05	193	146	6	e4ea7ce011a80b81b841c907719aa532bed39d2e
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT4 MXRA5 COL15A1 APCDD1 LEPR GSN	4.63e-05	196	146	6	e7bfd4fb400ae0c473131d0fa306c26be08a6d03
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT4 MXRA5 COL15A1 APCDD1 LEPR GSN	4.63e-05	196	146	6	82fad623212d986a7fca3496faf3f8c8f5b83a11
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT4 MXRA5 COL15A1 APCDD1 LEPR GSN	4.63e-05	196	146	6	85e5046f774537684e1443c0fc147d562b7068d0
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SLC46A2 IRX5 STARD10 CP BTG3 GALNT5	4.76e-05	197	146	6	ad6f047d003c08413264f39a30ba0f7639a257cd
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SLC46A2 IRX5 STARD10 CP BTG3 GALNT5	4.76e-05	197	146	6	1638959d7aecb9fc5285eb7e4a3103ca437989e2
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FLT3 COL15A1 MTMR11 CSF3R CSK PISD	4.76e-05	197	146	6	4a6eff66a17c5e89bda61d887b736f5c62b93bd7
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SLC46A2 IRX5 STARD10 CP BTG3 GALNT5	4.90e-05	198	146	6	d12f37527399038a8f030b45b176bda5c7c8a7ad
ToppCell	LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	IRX5 STARD10 CP BTG3 MARVELD2 GALNT5	5.03e-05	199	146	6	0447f8f53389fe7c6ddc04a97d86e74122ea16f4
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT4 MXRA5 COL15A1 APCDD1 LEPR GSN	5.03e-05	199	146	6	fb580e9321ddf97c73b2e356cd82523db74a38a2
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	ZFYVE16 CP LEPR ZIC5 MARVELD2 GALNT5	5.18e-05	200	146	6	5fb90118d3abc28d72bc483e68317255090a04c7
ToppCell	Sigmoid-ILC\|Sigmoid / Region, Cell class and subclass	PITPNM2 ABCB5 PPP1R15A TLE1 TNR TRIM74	5.18e-05	200	146	6	dfb06821f1019833f5d81f9c93808219b5fef407
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	COL15A1 FIGN SEZ6L2 ADRA1B HMCN2 SDK1	5.18e-05	200	146	6	913487e065dd580c9cbcbb3c3fc76a8d446f8856
ToppCell	Sigmoid-(3)_ILC\|Sigmoid / shred on region, Cell_type, and subtype	PITPNM2 ABCB5 PPP1R15A TLE1 TNR TRIM74	5.18e-05	200	146	6	a7326c43987a5eb4f4f5b48c4252cf4870432e5d
ToppCell	Sigmoid-(3)_ILC-(30)_ILC\|Sigmoid / shred on region, Cell_type, and subtype	PITPNM2 ABCB5 PPP1R15A TLE1 TNR TRIM74	5.18e-05	200	146	6	c39de94623383da7b2b260eb016ddaa5da7f4350
ToppCell	Sigmoid-ILC-ILC\|Sigmoid / Region, Cell class and subclass	PITPNM2 ABCB5 PPP1R15A TLE1 TNR TRIM74	5.18e-05	200	146	6	4ac1e6d7f358003e2448eb69e545772cd261c55f
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FAT4 MXRA5 COL15A1 APCDD1 LEPR HMCN1	5.18e-05	200	146	6	58b38f9a484ee94191091a0659ed62ebed2d4a14
Disease	carotene diol (2) measurement	PKD1L2 SCARB1	6.59e-05	3	139	2	EFO_0800171
Disease	carotene diol (1) measurement	PKD1L2 SCARB1	6.59e-05	3	139	2	EFO_0800170
Disease	myeloperoxidase (MPO)-DNA complex measurement	TSPOAP1 EPX LARS2	1.48e-04	22	139	3	EFO_0011039
Disease	Albuminuria	NPHS1 CP LEPR	1.93e-04	24	139	3	C0001925
Disease	myeloperoxidase measurement	TSPOAP1 SIRPB2 SMG8	2.46e-04	26	139	3	EFO_0005243
Disease	Pleocytosis	FLT3 CSF3R	3.26e-04	6	139	2	C0151857
Disease	Leukocytosis	FLT3 CSF3R	3.26e-04	6	139	2	C0023518
Disease	1,5 anhydroglucitol measurement	PKD1L2 FAM83G MGAM2	3.42e-04	29	139	3	EFO_0008009
Disease	Cataract	INTS1 PISD HSF4	7.07e-04	37	139	3	C0086543
Disease	Congenital small ears	SF3B4 KMT2D FGFR3	9.57e-04	41	139	3	C0152423
Disease	waist circumference	OVCH2 APCDD1 CYP17A1 STARD10 HECTD4 DGKQ SERP1 C2orf42	1.01e-03	429	139	8	EFO_0004342
Disease	Intellectual Disability	SET GAMT KDM3B ATL1 SUPT16H PISD TFB2M HNRNPR	1.31e-03	447	139	8	C3714756
Disease	tumor necrosis factor ligand superfamily member 8 measurement	DELEC1 GPR160	1.66e-03	13	139	2	EFO_0010592
Disease	Familial idiopathic steroid-resistant nephrotic syndrome	NPHS1 INF2	1.66e-03	13	139	2	cv:C4273714
Disease	diastolic blood pressure, alcohol consumption measurement	HECTD4 FIGN CSK	2.13e-03	54	139	3	EFO_0006336, EFO_0007878
Disease	Hypogonadotropic hypogonadism	CYP17A1 LEPR	2.22e-03	15	139	2	C0271623
Disease	Primary hypogonadism	CYP17A1 LEPR	2.22e-03	15	139	2	C0948896
Disease	Hypogonadism, Isolated Hypogonadotropic	CYP17A1 LEPR	2.22e-03	15	139	2	C3489396
Disease	Myopia	IRX5 RDH5	2.22e-03	15	139	2	C0027092
Disease	leukemia	FANCG CSF3R SYNCRIP	2.24e-03	55	139	3	C0023418
Disease	Hypogonadism	CYP17A1 LEPR	2.53e-03	16	139	2	C0020619
Disease	Astrocytosis	LEPR TNR	2.86e-03	17	139	2	C3887640
Disease	Gliosis	LEPR TNR	2.86e-03	17	139	2	C0017639
Disease	choline measurement	TENT4A NSL1 LEPR SCARB1	3.39e-03	130	139	4	EFO_0010116
Disease	hypertension	B3GLCT CYP17A1 HECTD4 FIGN SLC22A7 CSK	3.42e-03	307	139	6	EFO_0000537
Disease	carcinoma (implicated_via_orthology)	FAT4 FLT3 FLT4	3.46e-03	64	139	3	DOID:305 (implicated_via_orthology)
Disease	Global developmental delay	INTS1 KDM3B SUPT16H HNRNPR	3.67e-03	133	139	4	C0557874
Disease	neutrophil count, basophil count	FLT3 HECTD4 ZNF786 LEPR CSF3R	4.26e-03	224	139	5	EFO_0004833, EFO_0005090

Protein segments in the cluster

Peptide	Gene	Start	Entry
EWIPDILPQSKIGEL	C2orf42	521	Q9NWW7
ALPGWLEALRVALPV	EXOC3L1	271	Q86VI1
KQDPPGIDLASVEWL	DDX52	301	Q9Y2R4
IAALAAPAVEPKPAW	CDRT15L2	96	A8MXV6
VKVDLGIPLELWDEP	CNPY4	131	Q8N129
LAKQEGAWTILPLLP	B3GLCT	101	Q6Y288
ELPKESPLEVWLNLG	CSPG5	166	O95196
LIIPDKVWAVPDSLK	ALPK2	1266	Q86TB3
DSPPGALAELAKLAW	CIITA	651	P33076
ILKLNKPEWPFVVLG	ABCB5	681	Q2M3G0
RKEPFGLVLIIAPWN	ALDH3B1	101	P43353
PWAVLPLFLAVVGIA	GRM4	586	Q14833
EEISLPLWAVPAIVG	FAT4	4496	Q6V0I7
PPASALELKVWLELE	CDRT15P3	81	P0DPF6
VKPAVDPAAAKLWTL	CIAPIN1	186	Q6FI81
LLKATPVQVDGEPWV	DGKQ	881	P52824
QWLPRDKVLPLGVED	BRPF3	1146	Q9ULD4
EWKAPGALLSLPAPE	ADRA1B	446	P35368
GKLPVKWTAPEALRE	CSK	346	P41240
FIWVGPDNRLLEPDK	AMIGO2	321	Q86SJ2
EKICWLAIPEPNGVI	ADGRG7	606	Q96K78
WKEDFQGPVPLQLLL	CDAN1	1121	Q8IWY9
PEWVLVALAKGQLSP	ASTE1	326	Q2TB18
VEAVAEAWPGLVPTL	C17orf113	361	A0A1B0GUU1
EAWPGLVPTLEAAAL	C17orf113	366	A0A1B0GUU1
IEGLPAPIITWEKDQ	IGDCC4	166	Q8TDY8
PDGIVFDLLNIVPWL	PPIL2	56	Q13356
PKAVLENLDLWAGPL	TSPOAP1	841	O95153
PAVLAKPKLWSLAEI	IRX5	326	P78411
PADLQLLLDWVGAPA	MON1B	301	Q7L1V2
KPVWLGFLGPIIKAE	CP	86	P00450
PPVLWSRVDKEAALL	MDGA1	471	Q8NFP4
ELVVLDPPWDKELAA	NSL1	6	Q96IY1
AVQWAKDGLLLGPDP	NPHS1	61	O60500
PPVDWNDIAGLDLVK	FIGN	481	Q5HY92
VLLVPLAEPGVWVAE	LRP10	691	Q7Z4F1
KLTEVTWIDGGPVLP	MGAM2	1801	Q2M2H8
KAWPLLLVVAAFNPE	INTS1	736	Q8N201
APCGLELWRVLKPAE	IL31RA	226	Q8NI17
ILAWAPGVRKGLEPE	MTMR11	51	A4FU01
LLLPHIEGPEIKVWA	MTMR12	626	Q9C0I1
ELIAKDWPDGQAPIA	NLRP11	201	P59045
FPVPEIVWLKDAQLI	HMCN2	1371	Q8NDA2
DELVPLFEKAGPIWD	SYNCRIP	176	O60506
PLWLLKCQQEGLVPE	FBXO2	86	Q9UK22
NIDIWIGAIAEPLLP	EPX	611	P11678
ALPVKIVVDLGVAPW	GPR171	66	O14626
LVPLFEKAGPIWDLR	HNRNPR	181	O43390
LVWAPREDPVLLQGI	KDM3B	96	Q7LBC6
GKSAAAIALPPIAKW	LRBA	211	P50851
LVASAEQLLKELPWP	DPP3	346	Q9NY33
IGLLKISWEKPVFPE	LEPR	551	P48357
IPELLKWIEDGIPKD	GNG13	31	Q9P2W3
LWAEPASVIARGKPV	LILRB5	31	O75023
AALKEGSAWGPPLLE	FANCG	271	O15287
PGLPELDIGEVAAKW	PITPNM2	901	Q9BZ72
WKTLVGEPLDPEQDL	HECTD4	3726	Q9Y4D8
WKAGEPLLQGPDALA	POM121L12	16	Q8N7R1
APLLGNVLPWEDKLV	NPTXR	466	O95502
WPVTLGDAQALKPLK	INF2	1101	Q27J81
VVFGKWERPPLQLLE	TENT4A	281	Q5XG87
LFKALKVPSPALGWD	PKD1L2	1666	Q7Z442
PILTWLKDGVPVKAN	HMCN1	1671	Q96RW7
LKDIGLPLDPFVNWK	GPR160	301	Q9UJ42
LPQTPWIIDGERKLE	PUS10	301	Q3MIT2
TLPQLFLKVGEPLWI	FLT3	256	P36888
TPVIPALWEAKGLTL	ZNF561-AS1	21	K7EIQ3
IPWLLSPESLDIKEI	ATL1	301	Q8WXF7
LKAVEALASGAWPLP	FFAR1	61	O14842
WKSIVPAPGEGLLAV	DELEC1	11	Q9P2X7
EWCIAPIPDKGAVRL	GALNT5	856	Q7Z7M9
KDSLVDLVPWLKIFP	CYP17A1	211	P05093
WLVAAEDIPPSKLSV	CDON	766	Q4KMG0
FTWKLLIEAPEIPDL	IFIT1B	21	Q5T764
SDWILSVPAKLPEIE	DDX50	651	Q9BQ39
GPWDAILKAVKDQLP	DNAAF8	21	Q8IYS4
LPPKADLTIGLHGEW	APCDD1	281	Q8J025
WLGEPIKAAILPTSI	PRMT5	221	O14744
EASWALVGPLPLEAL	CSF3R	276	Q99062
PVPAFLGKLWALVGD	HSF4	16	Q9ULV5
PKTPFVLVVAGLAWI	MARVELD2	251	Q8N4S9
IPLKGLWEDVAPTLP	GAMT	111	Q14353
PGLQIWRVEKFDLVP	GSN	66	P06396
GELWALAVHPTKPLA	EML5	326	Q05BV3
LANVSELELPADPKW	FGFR3	451	P22607
DGWKKLQLGELIPIP	COL15A1	1171	P39059
PLAALLDGVWLSLPK	SLC22A7	481	Q9Y694
LLGLWVAEIPVSAKP	RNASE7	16	Q9H1E1
APGLISELKLAVPWG	SERHL2	6	Q9H4I8
KLLAWPADAPEAVTV	SDK1	906	Q7Z5N4
LAILSEAKWVPGVPG	SLFN13	761	Q68D06
WAAEANVLVLVLPGP	IRGQ	71	Q8WZA9
VVVLLWEAGAVPAPK	PRAP1	11	Q96NZ9
LPGLEPALQVDLVWA	TBRG4	401	Q969Z0
EKILSWPVVLPAVDS	LRRC43	496	Q8N309
PLEPWLVEAVKGAAL	PPP1R15A	41	O75807
FLVLWKDISPAALPG	PHF1	71	O43189
SDIGWVLELPKEEAP	FAM83G	521	A6ND36
APGLISELKLAVPWG	SERHL	6	Q9NQF3
KQEITLPPDGLWVLR	SMG8	941	Q8ND04
LTPVIPALWKAEAGG	C8orf17	71	Q9NRJ1
PALWKAEAGGLPELR	C8orf17	76	Q9NRJ1
AKPADSWELIIDPNL	RTP2	21	Q5QGT7
GLAPPALWDLAADKQ	PSMC2	71	P35998
PEKWNPVAGIVIALC	TRMT13	321	Q9NUP7
LAQVDPKGSLPKWVV	STARD10	186	Q9Y365
IWGPLELVEKLYPEA	RUFY2	71	Q8WXA3
ILFAAPPEKDILWDV	LARS2	666	Q15031
ISALIKIPGVWDPFV	TAF1A	226	Q15573
AGKKIELPTLWFPVL	OVCH2	546	Q7RTZ1
ELGEVIKDDIWPNPL	SET	216	Q01105
IEPVVLPLLWFAESG	SCARB1	406	Q8WTV0
LGIEAVPWTADIPLK	TFB2M	176	Q9H5Q4
SCPWIQGLPLKEEEI	SEZ6L2	21	Q6UXD5
EVPGFDKLVLIIPWV	SWT1	411	Q5T5J6
INAIPVASLDPIKEW	SUPT16H	871	Q9Y5B9
LVDAVLTWVLPKPAQ	RDH5	301	Q92781
WKAPAQPVGDIKFLL	REELD1	131	A0A1B0GV85
GASERPLQVPKEIWL	OCRL	726	Q01968
PKDWPLIIIDLKDCF	ERVK-9	1036	P63128
DVGVLPRWVPKEALT	SLC6A18	431	Q96N87
LGLPKELTLWVDPCE	BTG3	86	Q14201
DPLWIPFKEVAVTLI	NCAPD2	861	Q15021
LAWVIEALRLPGDPE	TRIM74	71	Q86UV6
SVLVKGAGDPEPDLW	SIRPB2	146	Q5JXA9
IWDLAAPTPRIKAEL	TLE1	556	Q04724
AVALLEELWGPAASP	ZNF444	91	Q8N0Y2
IEGWEPPKLALEDIS	TDRP	106	Q86YL5
APEEKASVGPWLLAL	SERP1	31	Q9Y6X1
LEIPPKLAGHWEVAL	PISD	96	Q9UG56
LPTPVDLELEWVLGK	PFAS	621	O15067
LGIPVVKLEKELPWG	ZSCAN25	16	Q6NSZ9
PFISVEWLKGPILEA	FLT4	331	P35916
PTEALLQWKAPVGEV	TNR	966	Q92752
VSLDDGLPKPELISW	ZNF786	46	Q8N393
IFKDDWIRPALLSGP	SLC30A6	331	Q6NXT4
QFLGILPDKVRPWVV	ZSCAN18	96	Q8TBC5
VDVIPLFVLREPLGW	SLC46A2	301	Q9BY10
LAWVIEALRLPGDPE	TRIM73	71	Q86UV7
PKDWPLIIIDLKDCF	ERVK-19	116	Q9WJR5
AVTAWEKGLESLPPL	MARS1	236	P56192
EPLLWELFLQAGPVV	SF3B4	26	Q15427
EWELIQESGVPLKPL	USP5	306	P45974
PFLCGILIQKLEIPW	ZFYVE16	1171	Q7Z3T8
IWELPDVVPFLQDGK	WDR64	591	B1ANS9
PLDIKLDLWEDLPAS	ZRANB3	761	Q5FWF4
LICKWIDPDELAGLP	ZIC5	396	Q96T25
LGLEVPGKLPVTTWE	KMT2D	4761	O14686
AKAAPLPSVRWVLGD	MXRA5	2071	Q9NR99
DDLGIPPEIWELLKG	MYBPC2	206	Q14324